Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2026-05-18 @ 1:55 PM
Study NCT ID:
NCT05828303
Status:
WITHDRAWN
Last Update Posted:
2025-04-01
First Post:
2023-03-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors
Sponsor:
Turning Point Therapeutics, Inc.
Organization: